ENTITY

OpGen (OPGN US)

7
Analysis
Health CareUnited States
OpGen, Inc. operates as a microbial genetics analysis company. The Company offers a platform for automated and microbial whole genome analysis that brings comparative genomics, whole genome sequence assembly, and strain characterization into the laboratory. OpGen serves customers throughout the United States.
more
bullishOpGen
14 Aug 2023 19:10Issuer-paid

OpGen - Cash concerns dampen active Q2

Despite the active second quarter with developments across all operational fronts, OpGen’s cash concerns have increased the risk of the company as...

Share
bullishOpGen
04 Aug 2023 21:46Issuer-paid

OpGen - FIND collaboration advances to development

OpGen has announced that Curetis (its German subsidiary) has signed an extended R&D collaboration agreement with FIND following the successful...

Share
bullishOpGen
21 Jul 2023 16:18Issuer-paid

OpGen - Feasibility milestone from FIND collaboration

OpGen has announced that Curetis (its German subsidiary) has met its objectives agreed under its extended R&D collaboration with FIND (a global...

Share
bullishOpGen
18 May 2023 01:06Issuer-paid

OpGen - Optimistic start to kick off a promising year

OpGen has reported a productive quarter marked by advancements across the board. Operating loss improved to $5.1m during the quarter (from $5.8m in...

Share
bullishOpGen
03 May 2023 16:16Issuer-paid

OpGen - $3.5m fund-raise to extend runway

In a bid to strengthen its cash position, OpGen has announced a c $3.5m (gross) fund-raise through an equity issue, subject to shareholders’...

Share
x